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Abstract 
 
We investigated the effects of punctual A-to-V and A-to-T mutations in the amyloid precursor 
protein APP, corresponding to position 2 of Aβ1–42. Those mutations had opposite effects on the 
onset and progression of Alzheimer Disease, the former inducing early AD pathology and the latter 
protecting against the onset of the disease. We applied Static and Dynamic Light Scattering and 
Circular Dichroism, to study the different mutants in the early stages of the aggregation process, 
essential for the disease. Comparative results showed that the aggregation pathways differ in the 
kinetics and extent of the process, in the size of the aggregates and in the evolution of the secondary 
structure, resulting in fibrils of different morphology, as seen by AFM. Mutated peptides had 
comparable toxic effects on N2a cells. Moreover, as assessed by X-ray scattering, all of them 
displayed disordering effects on the internal structure of mixed phospholipids-gangliosides model 
membranes.  
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1. Introduction 
 
The mechanisms underlying Alzheimer disease (AD) are not yet completely clear but genetic, 
pathological and biochemical aspects are at the basis of the onset and development of this 
pathology. In particular, the generation and accumulation of β-amyloid (Aβ) peptides, proteolytic 
fragments of the membrane-associated amyloid precursor protein (APP), represent a crucial aspect 
in the manifestation of this pathology [1]. Aβ peptides are extracellularly released in the brain as 
soluble macromolecules, then showing the tendency to form oligomeric, multimeric and fibrillar 
aggregates, thus triggering neurodegeneration. Soluble oligomers are now considered the main 
responsible for cognitive dysfunction, specially in the very early phases of the disease [2]. 
According to the amyloid cascade theory [3], the aggregation and accumulation processes of Aβ 
peptides end up with the formation of extracellular plaques that are considered the hallmarks of the 
disease. We first described a missense mutation in the alanine 673 residue of the amyloid precursor 
protein (APP), which corresponds to the second alanine of the amyloid A A2V sequence, with 
dramatic impact on homozygous carriers [4]. More recently, Jonsson et al (2012) [5] reported a 
mutation on the same alanine residue (A673T) that protects against the onset and development of 
Alzheimer disease and age-related cognitive impairment. The complete mechanism of this 
protective effect is not yet understood, although some studies on different cell models suggest that 
this last variant reduces the BACE1-mediated processing of APP, then lowering the levels of Aβ 
production [5,6]. Differences in the fibrillogenic propensity of the mutated peptides have also been 
claimed, but results on A A2T (both 1-40 and 1-42) are controversial, reporting either an effect on 
Aβ1-40A2T kinetics of aggregation [7], or a reduced level in Aβ1-42A2T aggregation but not in Aβ1-
40A2T [6]. We reported that the punctual mutation (A2V) increased the fibrillogenic properties of 
both Aβ1-40A2V and Aβ1-42A2 [4,8]. These observations contribute to underlining the critical role 
played by the N-terminal A region, which seems to affect the kinetics of oligomerization of 
peptides.  
In the present work we were interested in clarifying whether a single amino acid substitution A-to-T 
or A-to-V in position 2 could cause the global reorganization of the peptide structure. To this 
regard, we observe that the controversial results for A A2T were essentially obtained by the 
thioflavin T fluorescent dye method [6-7,9] that detects the presence of -sheet structures then 
inferring fibrillation. Conversely, in this work we applied a more direct and multi-technique 
approach, using Static and Dynamic laser Light Scattering and Circular Dichroism. We also 
used the so called “depsi peptide method” for A peptide synthesis, that enables obtaining seed-free 
batches of monomeric peptides [10-12]. 
We were able to compare in great detail the evolution from monomers toward fibrils of wild type 
A WT sequence and of the mutated A A2V and A A2T, and to unravel the different nature of 
the oligomeric structures of A peptides in the early stages of aggregation. We also compared the 
toxicity in vitro, on N2a cell lines, of the wild type peptide and the variants.  
Finally, we also studied the interaction of A A2V and A2T oligomers with model membranes 
using X-ray Scattering. With this technique one can observe the structural response of membranes 
to external stimulation. Soluble wild type Aβ oligomers are “membrane-active” species that can 
facilitate membrane puncturing and increase its permeability [13-15]. After interaction with the Aβ 
peptide, model membranes show structural rearrangement, with an expansion of the surface area 
and an alteration of their microviscosity [16-18]. We also recently studied the interaction of the A 
WT peptide with complex biomimetic membranes by Neutron Reflectometry [19] assessing how 
different stages of aggregation of the peptide result in different extent of interaction. Here we report 
that both mutated peptides induced changes in the structure of model membranes, revealing the A 
interaction with the hydrophobic core of the lipid membranes. 
The multi-technique approach may help in understanding how the various phenomena involved in 
A production and aggregation concur in determining the occurrence and timing of the pathological 
or protecting route. 
 
2. Materials and methods 
 
2.1 Peptide synthesis and samples preparation 
Aβ1-42 peptides were synthetized using depsipetide method as previously described [10-12]. Aβ1-
42WT, Aβ1-42A2V and Aβ1-42A2T (sequences in Supplementary Material) were stored in acidic 
solution (water:trifluoroacetic acid, 0.02%) at a concentration of ~200 µM. The depsi-peptide 
method allows to obtain a seed free batch, as much as possible near to monomeric condition. The 
method consists in introducing an O-acyl isopeptide structure between the Gly25–Ser26 residues, 
stable at acidic pH and able to inhibit the self-aggregation. On changing to basic pH (switching 
procedure), the peptide is converted into the Aβ1-42 native sequence. Before the switching 
procedure, to minimize the pre-aggregated species and to obtain the best reproducibility, peptides 
were dissolved in acidic solution (water:trifluoroacetic acid, 0.02%) at 1 mg/ml and ultracentrifuged 
o/n (at 55.000 rpm, 4°C) to obtain a seeds-free samples, filtered on a Microcon (centrifugal filter 
devices, c.o. 10 kDa, Millipore) and, finally, concentrated on a Microcon (centrifugal filter devices, 
c.o. 3 kDa, Millipore) up to a concentration ≥ 200 µM. The switching procedure of depsi-Aβ was 
carried out at basic pH, in particular a mix of sodium hydroxide (NaOH) and ammonium hydroxide 
(NH4OH) (ratio 3:1) was added to the peptide solutions to obtain final concentration of hydroxyl 
group of 10 mM (final pH of ~10) and incubated on ice for 10-15 minutes. 
Mixed model membranes for X-ray scattering investigation were prepared by dissolution of the 
desired lipids, dipalmitoylphoshatidylcholine (DPPC) and ganglioside (GM1), in appropriate 
organic solvent. After complete solvent evaporation under rotation, the lipid thin film was 
humidified and rehydrated (c = 20 mg/ml). Unilamellar vesicles formed spontaneously 
(DPPC:GM1 = 10:1.5 mol:mol).  
 
2.2 BACE activity assay 
BACE activity was carried out according to Ghosh & al. 2000 using as substrates the following 
three sequences: EVKMDAE (WT), EVKMDVE (A2V) and EVKMDTE (A2T) [20,21]. The 
BACE1 substrates were synthesized by solid-phase peptide synthesis on an automated synthesizer 
(Applied Biosystems 433A) using Fmoc-protected L-amino acid derivatives. The substrates were 
linked to a fluorescent dye (EDANS) on the glutammic acid in position 2 and to a quenching group 
(DABACYL) on the lysine in position 11. All peptides were purified in HPLC and their purity and 
identity were determined by MALDI-TOF analysis (model Reflex III, Bruker). BACE1 assay was 
carried out at 37ºC using 0,5 U of human recombinant BACE1 enzyme and different concentrations 
of substrate, 3.3, 6.6 and 10 µM, in 50 mM sodium acetate buffer (pH 4.5) in a final volume of 300 
l. Fluorescence was measured using a spectrophotofluorimeter (Perkin Elmer, Waltham, MA). 
Wavelengths of excitation and emission were 336 nm and 493 nm, respectively. The kinetics were 
followed for 90 min. 
 
 
2.3 Laser light scattering 
Both Dynamic and Static Laser Light Scattering (DLS and SLS) techniques were used. Experiments 
were carried out on a non-commercial apparatus equipped with a laser (= 532 nm), a digital 
correlator, and a thermostated cell [22]. High sensitivity is reached with four optical channels at 
90°, displaced 5° above or below the scattering plane, that allow independent parallel measurements 
of the intensity scattered from the same very dilute sample (about 0.1 mg/ml in the present work). 
Data reported in the Results were obtained by averaging the signal collected by all of the four 
independent optical channels. 
The three peptides (Aβ1-42WT, Aβ1-42A2V and Aβ1-42A2T) were analyzed immediately after the 
switching procedure, described in 2.1, followed by dilution to the final concentration of 25 M in 
phosphate buffer 50 mM, pH 7.4 at 22°C, by parallel and independent SLS and DLS. SLS average 
intensity depends on the molecular mass of particles in solution. So, the kinetics of aggregation of 
peptides was detected by acquiring the scattered intensity (SLS) for several days. The concentration 
being the same for all the samples and the measurements performed at the same temperature (22°C) 
with the same apparatus, differences in the scattered intensity could be directly related to 
differences in the number and molecular mass of the aggregates. Parallel measurement of the 
intensity correlation function (DLS) gave information on the translational diffusion coefficient of 
the particles and then, via the Stokes-Einstein equation, on the hydrodynamic radius of the 
aggregates. DLS data analysis was carried out using both the cumulants method, suitable to detect 
the evolution of the weight-average hydrodynamic size of particles in solution, and the NNLS 
method [23], suitable to determine their size distribution at different incubation times. 
 
2.4 Circular Dichroism (CD) 
Depsi peptides were switched as previously described and their initial secondary structures were 
determined at 4°C, immediately after dilution to the final concentration of 50 M in phosphate 
buffer 50 mM, pH 7.4. Then, temperature was raised to 37°C and the samples were analyzed for 24 
h in quiescent conditions (carrying out a scan every 30 minutes). CD spectra were recorded on a 
Jasco J-815 spectropolarimeter (Jasco, Easton, MD) from 200 to 260 nm (1.0-nm bandwidth and 
0.1-nm resolution) using a 0.1 cm path length quartz cell (sensitivity = 0.1 deg, response = 4 s, scan 
speed = 50 nm/min, 5 accumulations). The spectrum of appropriate buffer was subtracted, and the 
resulting CD spectra of the samples were expressed as mean molar ellipticity (). Deconvolution of 
the CD spectra was performed with the analysis program CONTIN [24] on an online server 
(DichroWeb).  
 
2.5 Atomic Force Microscopy (AFM) 
Depsi peptides were switched as previously described and diluted to the final concentration of 50 
M in phosphate buffer 50 mM, pH 7.4, then incubated in quiescent condition for 24 h. After 
incubation, all the samples were diluted to 5 M with PBS 50 mM, then 20 l were spotted onto 
freshly cleaved mica (Bruker AFM probes) at room temperature for five minutes and finally washed 
with 5 ml of milliQ water and dried under gentle nitrogen flow. AFM measurements were carried 
out on a Multimode AFM with a Nanoscope V system operating in tapping mode, using standard 
antimony-doped silicon probes (T: 3.75 µm, L: 125 µm, W: 35 µm, k: 40 N/m, f0: 300 kHz, Bruker 
AFM probes) with a scan rate in the 0.5-1.2 Hz range, proportional to the area scanned.   In order to 
exclude the interference of possible artifacts, freshly cleaved mica and freshly cleaved mica soaked 
with 20 l of PBS 50 mM, were also analyzed, as controls. All the topographic patterns were 
confirmed by measurements in a minimum of five different, well separated areas. 
 
2.6 X-ray scattering (SAXS, WAXS) 
Small angle X-ray scattering (SAXS) and wide angle X-ray scattering (WAXS) experiments were 
performed at the high-brilliance ID02 beamline of ESRF (Grenoble, France) in the region of 
momentum transfer 0.02 ≤ q ≤ 30 nm-1. Samples were put in plastic capillaries (KI-beam, ENKI) 
and mounted horizontally onto a thermostated multi-place sample holder, allowing for nearly 
simultaneous measurements on sample and reference cells. Very short exposure time was chosen 
(0.1 s), to avoid any radiation damage. The measured intensity profiles report the intensity of the 
scattered radiation as a function of the momentum transfer, q. To investigate a wide q-region, 
spectra relative to different q-ranges were joined, two for SAXS (with sample-to-detector distances 
of 1 m and 6 m) and one for WAXS, with an incident wavelength  = 0.1 nm. Several spectra 
relative to the empty cells and the solvent were taken, carefully compared and subtracted from each 
sample spectrum.  
 
2.7 In vitro toxicity assay 
To test the neurotoxicity of AβWT, AβA2T and AβA2V oligomers, the murine neuroblastoma N2a was 
used. To obtained soluble oligomers preparations, all depsi peptides after the switched procedure 
were diluted at 100 M in PBS 50 mM and incubated for 18 h at 4°C. N2a cell line was grown in 
Dulbecco's Modified Eagle's Medium (DMEM) containing 4.5 g/l glucose (Lonza) supplemented 
with 10
4
 U/ml penicillin/streptomycin (Gibco), 2 mM L-glutamine (Gibco) and 10% fetal calf 
serum (FCS, Lonza) at 37°C, in humidified atmosphere at 5% CO2. Confluent cells were 
trypsinized (0.025%, Gibco), resuspended in DMEM containing 1% FCS to minimize cell growth 
and plated at the concentration of 2x10
4
 cells/ml in transparent, flat bottom 96-multiwell plates 
(Corning). Cells were treated 4 hours after plating by adding 10 µl of different oligomeric Aβ1–42 
solutions to the medium, to the following final concentrations: 0.078 - 0.156 - 0.3125 - 0.625 - 1.25 
- 2.5 – 5 - 7.5 and 10 µM. Cell viability was determined 72 hours after treatment using a MTT 
reduction assay (Sigma Aldrich) and expressed as percent of control treated cell (with phosphate 
buffered saline) by mean ± standard deviation of four replicates.  
 
3. Results  
 
3.1 Effect of mutation on the -secretase activity. 
We initially examined the effect of the mutations on the BACE1 activity. Results are reported in 
Figure 1 for three different concentrations of the substrates after 90 min incubation. It can be seen 
that the BACE1 activity is nearly the same in the presence of either the A2T or the WT mutations, 
while it is highly increased for the A2V variant, the corresponding peptide being more easily 
cleaved from the corresponding parent APP. 
 
 
 
Figure 1. Recombinant β-secretase activity. Activity on APP carrying different mutations. (WT blue, A2V red, A2T 
green) determined with sequence-specific peptides containing the two reporter molecules EDANS and DABCYL. In the 
uncleaved form the fluorescent emission from EDANS is quenched by the physical proximity of the DABCYL moiety. 
Cleavage of the peptides by β-secretase physically separates the two reporters, enabling the release of the fluorescent 
signal at 493 nm. Concentrations of substrate: 3.3, 6.6 and 10 µM, in 50 mM sodium acetate buffer (pH 4.5). Delay 
from incubation: 90 min.  
 
3.2 Aggregation 
The aggregation propensity of the three Aβ peptides was investigated by laser light scattering. This 
technique readily reveals the emergence and growth of aggregates in solution, starting from 
monomers, as the measured scattered intensity (SLS) is proportional to the molecular mass of the 
scattering macromolecules. The depsi-peptide switching procedure was always used to avoid the 
presence of preformed seeds with high molecular mass, thus ensuring the monomeric starting point. 
The combination of depsi-peptide switching and radiation scattering observation has already proven 
to be well suited to follow the kinetics of aggregation of amyloidogenic peptides starting from 
monomeric condition [4,25,26]. In particular, in the case of Aβ1–42 peptides, a more pronounced 
propensity to aggregation was observed for the mutated A2V peptide as compared to the WT [8].  
The early stages of aggregation are deeply influenced by several parameters, such as concentration 
and temperature. For this reason, in order to compare the effect of either A-to-V or A-to-T 
mutations on the aggregation pathway of A, we applied the light scattering technique in the same 
experimental conditions to all systems. The aggregation was followed for at least 100 hours from 
switching, at 22°C on 25 M peptide solutions in phosphate buffer 50 mM, pH 7.4. Parallel 
measurements of the intensity correlation function yielded the size distribution of particles in 
solution. Results obtained for the three systems are reported in Figure 2 for comparison.   
 
  
 
 
Figure 2. Laser light scattering determinations. Top row. SLS Scattered intensity as a function of delay from 
dissolution for Aβ1–42 WT, A2V, A2T, 25 M at 22°C. The vertical scale is the same, so that the different extent of the 
scattered intensity growth can be appreciated. In the enlarged inserts, the fits of the observed kinetics, I(t) = Ifinal (1 - e
-
t/
), where Ifinal is the asymptotic value of the scattered intensity growth and τ is the characteristic time. WT, blue line: 
Ifinal = 0.08, τWT = 9 h; A2T, green line: Ifinal = 0.78,  τA2T = 6.5 h. 
Following rows. DLS intensity-weighted size distribution of aggregates of the Aβ1–42 peptides (WT, blue; A2V, red; 
A2T, green), at different delays from dissolution, namely 0-1 h, 20 h, 60 h and final, as indicated in the top row by the 
arrows. 
 
The initial intensity scattered from all samples was always very low, less than 1.5 times that of the 
pure solvent, as expected for very dilute solutions (about 0.1 mg/ml) of small particles. Data were 
obtained by averaging the signal collected by four different optical channels. The low scattered 
intensity confirmed that the peptides were present as monomers just after sample preparation. 
Looking at SLS results (Figure 2 first row), it is evident that the aggregation process for the three 
Aβ1–42 peptides was very different, both in the extent and in the kinetics. At a glance, Aβ1–42WT 
showed a definitely lower increase of the scattered intensity as compared to the two mutated 
peptides. Aβ1–42A2V displayed the highest intensity growth, even 100 times more than Aβ1–42WT, 
while Aβ1–42A2T displayed an intermediate maximum value. Also SLS time evolution showed 
distinctive features for the three peptides. Aβ1–42WT aggregation started after a long lag time (40 
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h). Aβ1–42A2T, after a shorter lag time (13 h), started a two-step aggregation process. The fitting 
curves reported in the inserts of Figure 2 were obtained by I(t) = Ifinal (1 - e
-t/
), where Ifinal is the 
asymptotic value of the scattered intensity growth and τ is the characteristic time, namely τWT = 9 h 
and τA2T = 6.5 h. Notably, the first step of  Aβ1–42A2T  kinetics came to an end before the onset of 
Aβ1–42WT aggregation. 
To examine these differences in deeper detail, we compared DLS parallel results on the size 
distributions of the aggregates (see Figure 2 following rows). Data are reported as intensity-
weighted size distributions at four different delays from dissolution, for each of the three peptides. 
At the beginning, monomers with size 2-3 nm were present in all systems, as the substantially 
predominant specie, > 80% relative intensity, corresponding to nearly 100% relative volume or 
number of particles.  
For Aβ1–42WT, at 20 h delay we detected the formation of intermediate aggregates of size 35 nm in 
coexistence with the population of monomers. Intermediate aggregates were few at this stage, as the 
intensity did not increase significantly. At 40 hours delay, a slight increase in intensity (insert to 
first row-left panel) was accompanied by the observation of two populations of aggregates with size 
60 nm and 400 nm. The size of the largest aggregates slowly increased above 1000 nm, but 
seemingly their number remained very low, as the population of small monomers was still 
detectable after 100 h.  
For Aβ1–42A2V, aggregation started immediately as a unique process leading to the formation of an 
increasing number of large aggregates, 500 nm in size. After 60 h monomers were no more 
detectable and at 90 h sedimentation of fibrils (size >2000 nm) occurred, as deduced by the final 
decrease of the scattered intensity (first row-central panel) 
For Aβ1–42A2T, , monomers disappeared to the benefit of the population of 500 nm (τA2T = 6.5 h) 
but in this case after a time lag of 13 hours. The number and the size of those aggregates reached a 
steady state (insert to first row-right panel), until, at 40 h delay, a second different process leaded to 
the formation of larger aggregates (fibrils of size >2000 nm) that, although fewer than in the case of 
Aβ1–42A2V, underwent earlier sedimentation (t = 65 h). 
 
The secondary structure of the Aβ peptides and the changes in their conformation due to peptide-
peptide interactions were determined by CD. In the case of A peptides, kinetics studies allow to 
follow the early changes of their secondary structure and in particular the detection of -sheet 
formation. Aβ1–42 WT, A2V, A2T were analyzed immediately after switching and dilution to a 
final concentration of 50 M at 37°C. Structural modifications were recorded for 24 hours with a 
scan every 30 minutes.  
 
 
 
Figure 3. Far-UV CD spectra of Aβ1-42WT, Aβ1-42A2V and Aβ1-42A2T. Depsi peptides were switched to native Aβ1-
42 sequences, diluted in 50 mM PBS buffer and immediately analyzed at 4°C (initial state, black lines). Temperature 
was increased to 37°C and the samples were incubated for 24 h in quiescent conditions (24 h, colored lines). Each 
spectrum corresponds at the mean of five accumulations. CD spectra were expressed as mean molar ellipticity. 
 
Results are reported in Figure 3 at 0 h (black lines) and 24 h (colored lines). After dilution, all 
peptides displayed a predominant random-coil conformation (negative peak in the region 200 nm). 
The evolution of the secondary structure of the three peptides (reported in the Supplementary 
Material, Figure S1) was different. In particular, Aβ1–42A2V rapidly evolved to β-sheet, as already 
visible after 3 hours, confirming the effect of the A to V mutation in inducing swifter structural 
change towards the fibril-forming conformations. Table 1 reports the quantitative analysis obtained 
by deconvolution of the spectra collected after 24 h from dissolution. For Aβ1–42A2V the relative 
abundance of random-coil dropped down from 41.1% to 21.1%, while the β-sheet conformation 
(peak at 218 nm in Figure 3, red line) grew to 49.4%. Notably, the Aβ1–42WT peptide showed a 
slower kinetics, although reaching a quite similar distribution of secondary structures after 24 h at 
37°C. Conversely, clear differences were detected for Aβ1–42A2T. The initial distribution was nicely 
similar to the others, with a high content of random-coil, while after 24 h the fraction of random-
coil conformation did not decrease dramatically, still remaining around 33.6%. Consistently, the 
fraction of β-sheet did not increase significantly, as visible in Figure 3 (peak at 218 nm, green line).  
Parallel examination of CD and light scattering results revealed that the different aggregation 
pathway observed for Aβ1–42A2T was accompanied by a different conformational evolution of the 
peptide. The soluble supramolecular aggregates formed by Aβ1–42A2T contained a lower fraction of 
β-sheet conformation. 
 
 
  Aβ1–42 WT  Aβ1–42 A2V  Aβ1–42 A2T 
  α βt β coil  α βt β coil  α βt β coil 
0 h  2.9 21.0 33.5 42.7  2.1 23.9 32.8 41.2  2.2 23.7 33.5 40.7 
24 h  7.9 22.3 47.8 22.0  7.2 22.1 49.4 21.2  7.8 23.4 35.2 33.6 
 
Table 1. The content of secondary structures predicted by CD spectra using the CONTIN algorithm for Aβ1–42 WT, 
A2V, A2T (50 M, 37°C). Fractional distribution (%) of different secondary structures, (α) α-helix, (βt) β-turn, (β) β-
sheet, (coil) random-coil. 
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AFM was employed for morphological characterization of the 24-h-delay molecular assemblies of 
the three A peptides present in the solutions used for CD analysis. The A1-42WT sample was 
mainly composed by an abundant meshwork of mature protofibrillar structures with typical turn-
loop, whereas the mutated peptides evolved in mature fibrillar structures, indicating higher 
fibrillogenic propensity. (Figure 4) 
 
 
 
Figure 4. Analysis of Aβ1-42WT, Aβ1-42A2V and Aβ1-42A2T in tapping mode atomic force microscopy (amplitude 
data). Aβ1-42 peptides switched were diluted to 50 M in 50 mM phosphate buffer at 37°C in quiescent conditions and 
analyzed after 24 h after dilution to a final concentration of 5 M. AFM images reported in Figure are representative of 
a minimum of five different, well separated areas. The scale bars correspond to an amplitude range of – 35 / + 60 mV 
for all panels. 
 
 
3.3 Interaction with model membranes 
To compare the propensity of the two mutated Aβ1–42A2V, Aβ1–42A2T peptides to interact with 
membranes, we performed X-ray scattering experiments on model vesicles, containing DPPC 
phospholipid  and GM1 ganglioside. 
Closed unilamellar model membranes were prepared at 20 mg/ml of total lipid and then submitted 
to the interaction with mutated Aβ peptides (25 M), at T = 50°C, well above the transition 
temperature of DPPC. Parallel Small and Wide Angle X-ray scattering measurements (SAXS and 
WAXS) were performed for the different systems. These techniques enable to obtain detailed 
information on the structure of the lipid bilayers constituting the model membranes.  
All the recorded SAXS intensity profiles, reported in Figure 5, showed the typical features of closed 
unilamellar vesicles. Clearly, the spectra of the mixed systems (Aβ1–42A2V red points, Aβ1–42A2T 
green diamonds) were very similar to each other and both different from the one of the naked 
membrane (black triangles), indicating that interaction occurred between both peptides and the 
model membrane.   
 
 
 
Figure 5. Small angle X-ray (SAXS). Spectra of model membrane solutions (DPPC:GM1 = 10:1.5) naked (black) and 
in presence of Aβ1–42A2V (red) and Aβ1–42A2T (green) peptides.   
 
Parallel measurements in the WAXS spectral region, corresponding to distances typical of the local 
scale, confirmed this finding. As shown in Figure 6, the intensity peak for the naked membrane was 
qpeak= 14.8, corresponding to a mean distance d = 0.424 nm between lipid chains in the fluid phase. 
In the mixed systems the sharpness of the WAXS peak was reduced and its position was moved to 
lower q values, indicating that the presence of Aβ1–42 peptides induced a higher degree of disorder 
in the packing of the lipid chains within the membrane core. The same disordering effect could be 
inferred from the observed modification of the SAXS spectra shown in Figure 5. 
 
 
 
 
 
Figure 6. Wide angle X-ray (WAXS). Spectra of model membrane solution ( DPPC:GM1 = 8:2 ) naked (black) and in 
presence of Aβ1–42A2V (red) and Aβ1–42A2T (green) peptides. Peak at qpeak = 14.8 nm
-1 
(black). 
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3.4 Toxicity 
The cell viability of the neuroblastoma N2a after treatment with various concentrations of Aβ1-
42WT, Aβ1-42A2V and Aβ1-42A2T peptides was assessed. Figure 7 reports the cell viability 72 hours 
post administration of the different oligomeric peptides solutions in the concentration range 0.078 - 
10 µM. The dose corresponding to 50% cell viability (EC50) were, 5 µM for WT, 1.05 µM for A2V 
and 2.5 µM for A2T. Therefore the toxicity for the three peptides could be ranked as Aβ1-42A2V > 
Aβ1-42A2T > Aβ1-42WT.  
 
 
 
Figure 7. Neurotoxicity of Aβ1-42WT, Aβ1-42A2V and Aβ1-42A2T oligomers. N2a cell viability after treatment with 
oligomers preparations at different concentrations (0.078-0.156-0.3125-0.625-1.25-2.5-5-7.5-10 µM) for 72 hours. Each 
point was mean ± standard deviation of four replicates, *p<0.05, **p<0.01, ***p<0.001 versus control (phosphate 
buffered saline), one-way ANOVA followed by Tukey’s post hoc test. A horizontal dotted line marks the EC50 values. 
 
 
4. Conclusions 
 
We investigated the effects of punctual A-to-V and A-to-T mutations in position 673 of the amyloid 
precursor protein APP, in the N-terminus region, corresponding to position 2 of the Aβ1–42 
peptide, on its aggregative properties and on its propensity to interact with membranes. Those 
mutations have opposite effects on the onset of AD, A-to-V inducing early onset of AD in the 
homozygous, while A-to-T preventing the pathology. Concerning the Aβ peptide production by β-
secretase activity, we found that the A2V mutation enhanced APP processing, while the A2T 
mutation resulted in similar level of Aβ production as compared to the wild type.  Still we found 
that this is not the only difference. We applied a multi-technique approach to study the structural 
and morphological features of the three Aβ peptides on different length-scales. 
We applied static and dynamic laser light scattering techniques and CD to study the aggregation 
process of Aβ1–42WT, Aβ1–42A2V and Aβ1–42A2T in the early stages. These correspond to the 
soluble-oligomers/structured-oligomers regime, where aggregates are claimed to be essential for the 
noxiousness in vivo and then for the onset and the advancement of the disease. We took advantage 
of the so called “depsi peptide method” for A peptide synthesis, that enables obtaining seed-free 
batches of monomeric peptides. 
Comparative results indicated distinctive pathways of monomers aggregation that differed in the 
kinetics and the extent of the process, in the size of aggregates, in the evolution of the secondary 
structure of the peptides. This means that at a given concentration, at the same delay from 
production within a certain time lag, the three peptides display a different propensity to establish 
and stabilize interactions with similar molecules. This suggests that oligomeric species with 
different reactivity towards their surrounding medium may occur, with different outcomes. 
Notably, Aβ1–42WT had the lowest propensity for aggregation, and in fact monomers were still 
observed at long delay from dissolution.  
A-to-V mutation significantly increased the number and size of Aβ1–42A2V aggregated structures, 
leading to fibril formation. Accordingly, the secondary structure of the mutated Aβ1–42A2V peptide 
evolved faster to β-sheet conformation.  
The behavior of Aβ1–42A2T was complex. A double-step kinetics led to the formation of 
intermediate aggregated structures before the appearance of a small number of fibrils, In parallel we 
also observed a slower folding kinetics: the distribution of secondary structures did not evolve 
rapidly towards an increasing amount of β-sheet. Thus Aβ1–42A2T aggregates were different from 
the usual pre-fibrillar ones observed in Aβ1–42A2V, on different length-scales. The present findings 
agree with recent studies on monomers conformations [27] showing that the A-to-T mutation can 
dramatically alter the -hairpin population and switch the equilibrium towards alternative 
structures. Moreover the observed time evolution of the collection of aggregates suggests that the 
intermediate aggregates did not evolve simultaneously towards the progressive formation of pre-
fibrillar and fibrillar structures, but spare fibrils were formed randomly in solution. These fibrils 
immediately precipitated, as observed by laser light scattering, and were therefore no longer present 
in the solution to give the characteristic contribution to CD spectra. Early spare fibril sedimentation 
could also have affected the controversial results obtained by thioflavin T fluorescent dye method 
[6-7,9], that follows the fibrillation process by detecting the -sheet signal. 
Both Aβ1–42A2V and Aβ1–42A2T peptides had higher toxicity than Aβ1–42WT. The dose response 
curve on neuroblastoma N2a cells viability indicated Aβ1-42A2V was the most toxic, with an onset 
of effectiveness and 50% cell viability at 72h at the lower dose. 
Finally, we directly observed the interaction of Aβ1–42A2V and Aβ1–42A2T peptides with model 
membranes, at early stages of aggregation. Both peptides had a propensity to interact with 
membranes, leading to a decrease in the lipid core density and an increase in the disorder of the 
chains packing.  
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